Author Question: A patient with pulmonary emboli has severe hypoxemia, acute right-sided heart failure, and shock. ... (Read 85 times)

LaDunn

  • Hero Member
  • *****
  • Posts: 526
A patient with pulmonary emboli has severe hypoxemia, acute right-sided heart failure, and shock. What treatment should be given at this time?
 
  a. Acetylcholine esterase
  b. Heparin
  c. Streptokinase
  d. Warfarin

Question 2

What drug would be the treatment of choice for pulmonary emboli?
 
  a. Heparin
  b. Streptokinase
  c. Urokinase
  d. Warfarin



Mochi

  • Sr. Member
  • ****
  • Posts: 300
Answer to Question 1

ANS: C
In the care of patients with severe hypoxemia, acute right-sided heart failure, or shock, thrombo-lytic therapy may be administered for lysis of the emboli. However, for patients with no evidence of hypotension, thrombolytic administration has to be individualized. When thrombolytic therapy with streptokinase and urokinase is used, heparin should not be infused concurrently.

Answer to Question 2

ANS: A
Therapy with heparin, whether unfractionated or low molecular weight, followed by oral couma-rin in a regimen similar to that for acute deep venous thrombosis is the treatment of choice.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In 1835 it was discovered that a disease of silkworms known as muscardine could be transferred from one silkworm to another, and was caused by a fungus.

Did you know?

Vital signs (blood pressure, temperature, pulse rate, respiration rate) should be taken before any drug administration. Patients should be informed not to use tobacco or caffeine at least 30 minutes before their appointment.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

The FDA recognizes 118 routes of administration.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library